Danish dermatology specialist Leo Pharma and its CEO Christophe Bourdon came to San Francisco to attend the J.P. Morgan ...
Pharmaceutical companies are increasingly turning to artificial intelligence to accelerate R&D, betting on new modeling tools ...
Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved ...
According to reporting from Bloomberg at the J.P. Morgan Healthcare Conference that ended today in San Francisco, ...
Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...
Teva has penned a second pact with Royalty Pharma, this time securing up to $500 million to support the clinical development ...
HRV Pharma’s innovative “virtual manufacturing” model connects FDA-approved facilities to prevent prescription shortages and ...
From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced ...
AbbVie struck a big deal to enter the hot PD-1xVEGF bispecific space. | In this week's Asia news recap, AbbVie struck a big ...
U.S. biotech share sales deliver biggest first week since 2021; President Trump claims he'll unveil long-awaited framework ...